J. David Enloe, Jr
2022
In 2022, J. David Enloe, Jr earned a total compensation of $2.3M as President and Chief Executive Officer at Recro Pharma, a 107% increase compared to previous year.
Compensation breakdown
| Bonus | $400,000 |
|---|---|
| Option Awards | $498,982 |
| Salary | $572,115 |
| Stock Awards | $749,999 |
| Other | $50,444 |
| Total | $2,271,540 |
Enloe received $750K in stock awards, accounting for 33% of the total pay in 2022.
Enloe also received $400K in bonus, $499K in option awards, $572.1K in salary and $50.4K in other compensation.
Rankings
In 2022, J. David Enloe, Jr's compensation ranked 1,576th out of 5,534 executives tracked by ExecPay. In other words, Enloe earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,576 out of 5,534 | 72nd |
Division Manufacturing | 803 out of 3,000 | 73rd |
Major group Chemicals And Allied Products | 314 out of 1,350 | 77th |
Industry group Drugs | 291 out of 1,253 | 77th |
Industry Pharmaceutical Preparations | 207 out of 907 | 77th |
Source: SEC filing on April 6, 2023.
Enloe's colleagues
We found one more compensation record of an executive who worked with J. David Enloe, Jr at Recro Pharma in 2022.
2022
Ryan Lake
Recro Pharma